24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Prenatal and perinatal genetics<br />

from the fourth pregnancy combined with amniotic fluid investigation<br />

<strong>of</strong> the fifth pregnancy using glycosaminoglycan electrophoresis and<br />

lysosomal enzyme activity measurements confirmed beta-glucuronidase<br />

deficiency in both. Cord blood investigation revealed prominently<br />

vacuolated monocytes, with basophilic inclusions in lymphocytes<br />

(Gasser cells) and metachromatic granules (Alder-Reilly bodies) in<br />

granulocytes. Electron microscopic investigations showed vacuolated<br />

H<strong>of</strong>bauer cells in the placenta and foamy macrophages in spleen, liver,<br />

and other organs. Greatly reduced activity <strong>of</strong> beta-glucuronidase in<br />

cultured skin fibroblasts reconfirmed the diagnosis <strong>of</strong> MPS type VII and<br />

GUSB DNA analysis is still pending. We can conclude that recurrent<br />

massive non-immune hydrops foetalis is likely autosomal recessive<br />

with 25% recurrence risk in which lysosomal storage disorders need<br />

to be investigated.<br />

P05.22<br />

Achivements in the NiPD <strong>of</strong> monogenic disorders: a prenatal<br />

diagnosis unit experience<br />

A. Bustamante Aragones 1,2 , C. Gonzalez Gonzalez 3 , M. Rodriguez de Alba 1,2 ,<br />

E. Vallespin 4 , M. Garcia Hoyos 1,2 , J. Gallego Merlo 1,2 , E. Ainse 1,2 , C. Perez<br />

Cerdá 5,2 , M. Trujillo Tiebas 1,2 , C. Ramos 1,2 ;<br />

1 Fundacion Jimenez Diaz-Capio, Madrid, Spain, 2 CIBERER, Spain, 3 Megalab,<br />

Madrid, Spain, 4 Hospital La Paz, Madrid, Spain, 5 Universidad Autónoma de<br />

Madrid, Madrid, Spain.<br />

Non-invasive prenatal diagnosis (NIPD) using fetal DNA in maternal<br />

plasma has proven its potential for the study <strong>of</strong> the fetus. Many diagnostic<br />

units are currently <strong>of</strong>fering non-invasive fetal sex assesment for<br />

X-linked disorders and Rh determination in Rh(-) pregnant women.<br />

As for the monogenic disorders, since the fetal DNA circulates within a<br />

high background <strong>of</strong> maternal DNA, NIPD is mainly based on the study<br />

<strong>of</strong> paternal alleles, absent in the maternal genome. This limits this approach<br />

to pregnancies in which the father is carrier <strong>of</strong> an autosomal<br />

dominant mutation or those in which both parents are carriers for different<br />

autosomal recessive mutations.<br />

The clinical incorporation <strong>of</strong> NIPD for monogenic disorders must fulfil<br />

the same needs <strong>of</strong> the conventional molecular prenatal diagnosis.<br />

We have studied 14 paternal mutations associated to different diseases:<br />

X-linked retinitis pigmentosa, congenital Leber amaurosis, cystic<br />

fibrosis, propionic acidemia and Huntington disease.<br />

The diagnosis was performed by the use <strong>of</strong> different analytical methods<br />

currently used in the clinical practice.<br />

The fetal condition for the paternal mutation was correctly diagnosed<br />

in 13 out <strong>of</strong> the 14 cases. The remaining case could not be diagnosed<br />

due to the length <strong>of</strong> the mutant allele.<br />

NIPD <strong>of</strong> monogenic diseases could be the forthcoming study to be <strong>of</strong>fered<br />

in clinical practice. The study <strong>of</strong> monogenic disorders in maternal<br />

plasma must be individualized and directed. As a Prenatal Diagnosis<br />

Unit we are aware <strong>of</strong> the importance <strong>of</strong> having different diagnostic tools<br />

available to get to a reliable diagnosis for each individual case.<br />

P05.23<br />

A case <strong>of</strong> partial trisomy 3q in a fetus<br />

O. Nikolayeva, L. Bogodukh, T. Petrova, S. Ripp;<br />

Family Planning and Reproduction Centre, Astrakhan, Russian Federation.<br />

A married couple underwent cytogenetic testing following the detection<br />

<strong>of</strong> abnormalities in a fetus 25 weeks. The father was 22 years old,<br />

the mother was 23 years old, and this was their 3 rd pregnancy. Fetal<br />

ultrasound had revealed multiple congenital abnormalities including<br />

congenital heart disease, common arterial trunk, a 4mm defect <strong>of</strong> interventricular<br />

septum, and Dandy-Walker syndrome. The mother’s karyotype<br />

was 46,xx, inv (3) (p2.5 q2.1). Cordocentesis allowed karyotyping<br />

<strong>of</strong> the fetus and revealed: 46,xx,der(3) (3qter-cen 3p2.5::3q2.1-3qter),<br />

resulting in partial trisomy <strong>of</strong> the long arm <strong>of</strong> the 3 rd chromosome as<br />

a result <strong>of</strong> recombination inv(3) by the mother. The pregnancy was<br />

subsequently aborted. Fetal pathology revealed: body mass 570g,<br />

length 21cm. The sex was indeterminate. There was acrocephaly, high<br />

forehead, and hypertelorism. The nose is small and flat with broad<br />

nostrilis, and the bridge was sunken. The ears were low.<br />

The fetus also had contracture <strong>of</strong> knee and talocrucal joints. The lower<br />

limbs were adducted to the trunk, and there was lower limb syndactyly.<br />

The upper extremities are without pathology. There was agenesis <strong>of</strong><br />

the urinary bladder, the ureters flowing into a broadened rectum. No<br />

internal sexual organs were detected.<br />

P05.24<br />

Overview <strong>of</strong> Prenatal Diagnosis (PND) in our country (iran)<br />

M. H. Kariminejad, Azadeh Moshtagh, Farnaz Azimi, Nasrin<br />

NabaviNia,Mahnaz Pirveissi,Narges Miraftabi,Roxana Kariminejad;<br />

Kariminejad & Najmabadi Pathology & <strong>Genetics</strong> Center, Tehran, Islamic Republic<br />

<strong>of</strong> Iran.<br />

Prenatal diagnosis became a generally accepted tool for prevention <strong>of</strong><br />

genetics disorders since the 1980s. Simultaneously Iranian geneticists<br />

and clinicians <strong>of</strong> related fields attempted to establish this procedure in<br />

our country.<br />

It was a great challenge, it took a long time to be overcome the problems,<br />

including legal approval initially granted for hemoglobinopathies<br />

at 1996 and thereafter for other genetic disorders including chromosomal<br />

abnormalities, metabolic diseases MPS, lipid lysosomal storage<br />

diseases: Single aminoacids, muscular dystrophies, myopathies<br />

(SMA), triple nucleotide repeats, Skin lesions and mitochondrial diseases.<br />

Hereby the results, and the practical problems encountered in eleven<br />

thousand chromosomal study <strong>of</strong> amniotic fluid samples are presented.<br />

The pregnant ladies are classified according to clinical indications as<br />

follows: Maternal age over 30 years, history <strong>of</strong> <strong>of</strong>fspring with chromosomal<br />

aberration, the similar group with advanced maternal age, balanced<br />

chromosomal aberration in either parents, loss <strong>of</strong> <strong>of</strong>fspring pre<br />

or postnatal death, high sick <strong>of</strong> chromosomal abnormalities according<br />

to triple, quadruple, and 1 st trimester fetal screening tests.<br />

P05.25<br />

Prenatal Down’s syndrome screening in st.Petersburg in 2008<br />

T. K. Kascheeva 1 , Y. A. Nikolaeva 1 , M. V. Krechmar 1 , N. V. Vokhmyanina 2 , T. V.<br />

Kuznetzova 1 , O. P. Romanenko 2 , V. S. Baranov 1 ;<br />

1 Ott’s Institute <strong>of</strong> Obstetrics and Gynecology RAMS, Saint-Petersburg, Russian<br />

Federation, 2 City Medical Genetic Center, Saint-Petersburg, Russian Federation.<br />

There is a growing interest in the shift <strong>of</strong> prenatal screening to the<br />

first trimester. Such screening relies on the maternal age, free β-hCG,<br />

PAPP-A plus NT. The second trimester screening in Saint-Petersburg<br />

is performed for all pregnant women before 35, the first trimester<br />

screening - for all at the age 35 and more. Since 2004 combined<br />

screening was initiated in Saint-Petersburg. Down syndrome (DS) detection<br />

rate was 94.5% (52/55) (cut <strong>of</strong>f 1/250, FPR 5.8%). Altogether<br />

42111 (82.5%) pregnancies were tested in 15-17 weeks. Detection<br />

rate in 2-d trimester was 75% (24 <strong>of</strong> 32) (1/360, FPR 7.0%). 2705 <strong>of</strong><br />

pregnant women <strong>of</strong> 35 age and more (36%) were tested in first trimester.<br />

Detection rate in 1-t trimester was 100% (17 <strong>of</strong> 17) (1/250, FPR<br />

16.0%). Many women from them participated in the both screenings.<br />

Since 2008, February the simple calculation formula has been suggested<br />

for DS risk estimation in the women subjected to both screening<br />

tests. According to this formula the final risk is equal to the risk <strong>of</strong><br />

the 1st trimester multiplied by the risk <strong>of</strong> the second one and divided<br />

by age risk. In that case the number <strong>of</strong> FPR reduces almost twice. But<br />

application <strong>of</strong> two steps screening is economically unjustified. Second<br />

screening could be recommended only to the women with risk about<br />

0.05 and 0.4% after the 1 st trimester screening. This group contributed<br />

only 17% <strong>of</strong> all pregnancies in 2008. More sophisticated decision concerning<br />

application <strong>of</strong> contingent screening could be taken after some<br />

economical considerations.<br />

P05.26<br />

Prenatal diagnosis <strong>of</strong> mucopolyssaccharidoses in Egypt:<br />

counseling aspects, sampling techniques and biochemical<br />

diagnosis<br />

E. M. A. F. Fateen1 , A. A. L. A. Aboul Nasr2 ;<br />

1 2 National Research Centre, Cairo, Egypt, Cairo University, Cairo, Egypt.<br />

Objective: prenatal diagnosis <strong>of</strong> mucopolysaccharidoses in pregnant<br />

females with previously affected child<br />

Subjects: The present study included 35 pregnant females with previously<br />

affected MPS child or more. 10 type I (Hurler), 9 type II (Hunter),<br />

5 type IIIb (Sanfilippo), 3 type IVa (Morquio) and 8 type VI (Maroteaux-<br />

Lamy)<br />

Consanguineous marriage was present in 30 (85.7%) couples. 15<br />

families have no normal children and 20 families have normal children.<br />

However families with no normal males are 27.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!